Genzyme, a company producing therapies for rare diseases, received FDA clearance for its manufacturing plant in Framingham, Mass., for the production of Fabrazyme, an enxyme replacement therapy for ...

Genzyme Corp. (Sanofi Genzyme) has disclosed sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, among others.

French drugmaker Sanofi-Aventis has agreed to buy Genzyme Corp for $20.1 billion ... Massachusetts, Genzyme has about 10,000 employees and posted revenue in 2009 of $4.5 billion.

Genzyme Corp. (Sanofi Genzyme) has divulged emopamil-binding protein (EBP) inhibitors reported to be useful for the treatment of multiple sclerosis, transverse myelitis, neuromyelitis optica, optic ...